Form 4 for EW Edwards Lifesciences
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-03 · accession 0001225208-23-005434 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-04 | 2023-05-03+ | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $87.96 | -671 | 27.4K | -2% | -$59.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-03 | F | D | 327 | $87.81 | 27,696.78 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-04 | F | D | 344 | $88.10 | 27,352.78 | D | — | — |